Previous close | 0.0692 |
Open | 0.0692 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 0.0692 - 0.0692 |
52-week range | 0.0350 - 0.1560 |
Volume | |
Avg. volume | 139 |
Market cap | 7.838M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0600 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Jack Nathan Medical ( CVE:JNH ) Full Year 2023 Results Key Financial Results Revenue: CA$15.5m (up 61% from FY 2022...
TORONTO, June 02, 2023--Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) ("Jack Nathan Health", "JNH" or the "Company") announced today its audited consolidated annual financial results for the fourth quarter of fiscal 2023, and fiscal year ended January 31, 2023. Jack Nathan Health’s financial statements are prepared in accordance with International Financial Reporting Standards ("IFRS").
TORONTO, December 28, 2022--Jack Nathan Medical Corp. (TSXV: "JNH"; OTCQB: "JNHMF") (the "Company") is pleased to announce that all of the matters presented for approval at its annual and special meeting of shareholders of the Company (the "AGM") held on Friday, December 23, 2022 were approved. The AGM was originally called for December 2, 2022, but was adjourned until December 23, 2022 (see the Company’s press release dated December 2, 2022).
TORONTO, December 22, 2022--Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) ("Jack Nathan Health", "JNH" or the "Company") announced today its unaudited interim consolidated financial results for the third quarter of fiscal 2023. Jack Nathan Health’s financial statements are prepared in accordance with International Financial Reporting Standards ("IFRS").
TORONTO, December 03, 2022--Jack Nathan Medical Corp. (TSXV: "JNH"; OTCQB: "JNHMF") (the "Company") reports that it has adjourned its annual and special meeting of shareholders of the Company (the "AGM") until 1:30 p.m. (Toronto time) on Friday, December 23, 2022. The adjourned meeting will be held in person on December 23 (rather than via zoom and teleconference) at the offices of Dickinson Wright LLP, 199 Bay Street, Suite 2200, Commerce Court West, Toronto Ontario, Canada. The rescheduling of
TORONTO, September 29, 2022--Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) ("Jack Nathan Health", "JNH" or the "Company") announced today its unaudited interim consolidated annual financial results for the second quarter of fiscal 2023. Jack Nathan Health’s financial statements are prepared in accordance with International Financial Reporting Standards ("IFRS").
TORONTO, September 27, 2022--Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) ("Jack Nathan Health", "JNH" or the "Company") and Wal-Mart Canada Corp. ("Walmart Canada") announce today that they have entered into a loan agreement (the "Loan Agreement") in order to establish a new revolving credit facility in an amount not to exceed CAD$2,000,000 (the "Loan") in favour of the Company maturing on a date that is the earlier of (i) the date upon which demand is made by Walmart Canada pursuant to
TORONTO, September 20, 2022--Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) ("Jack Nathan Health", "JNH" or the "Company") announces that David Berman stepped down from his position as Chief Financial Officer of the Company effective as September 19, 2022. "On behalf of myself and the board of directors, we want to thank David for his contributions to Jack Nathan Health. He has been a key contributor to our success to date, and we wish him the best in his future endeavors," said Dr. Glenn C
TORONTO, June 30, 2022--Jack Nathan Health Announces Q1-Fiscal 2023 Financial Results.